ATE98649T1 - Reinigung von lfa-3. - Google Patents
Reinigung von lfa-3.Info
- Publication number
- ATE98649T1 ATE98649T1 AT88301709T AT88301709T ATE98649T1 AT E98649 T1 ATE98649 T1 AT E98649T1 AT 88301709 T AT88301709 T AT 88301709T AT 88301709 T AT88301709 T AT 88301709T AT E98649 T1 ATE98649 T1 AT E98649T1
- Authority
- AT
- Austria
- Prior art keywords
- lfa
- cleaning
- quantitating
- purifying
- useful
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/70503—Immunoglobulin superfamily
- C07K14/70528—CD58
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/2803—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily
- C07K16/2806—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily against CD2
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/2803—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily
- C07K16/2824—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily against CD58
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Immunology (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- General Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Transplantation (AREA)
- Gastroenterology & Hepatology (AREA)
- Zoology (AREA)
- Toxicology (AREA)
- Cell Biology (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
- Removal Of Specific Substances (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Treatment Of Liquids With Adsorbents In General (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US1901087A | 1987-02-26 | 1987-02-26 | |
EP88301709A EP0280578B1 (de) | 1987-02-26 | 1988-02-26 | Reinigung von LFA-3 |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE98649T1 true ATE98649T1 (de) | 1994-01-15 |
Family
ID=21790939
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT88301709T ATE98649T1 (de) | 1987-02-26 | 1988-02-26 | Reinigung von lfa-3. |
Country Status (6)
Country | Link |
---|---|
EP (1) | EP0280578B1 (de) |
JP (1) | JPS63276494A (de) |
AT (1) | ATE98649T1 (de) |
CA (1) | CA1326940C (de) |
DE (1) | DE3886237T2 (de) |
ES (1) | ES2061638T3 (de) |
Families Citing this family (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5185441A (en) * | 1988-08-26 | 1993-02-09 | Biogen, Inc. | Dna sequences, recombinant dna molecules and processes for producing pi-linked lymphocyte function associated antigen-3 |
US6514936B1 (en) | 1988-09-01 | 2003-02-04 | Bayer Corporation | Antiviral methods using human rhinovirus receptor (ICAM-1) |
US6143298A (en) * | 1988-09-01 | 2000-11-07 | Bayer Corporation | Soluble truncated forms of ICAM-1 |
ZA896668B (en) * | 1988-09-01 | 1990-06-27 | Molecular Therapeutics Inc | A human rhinovirus receptor protein that inhibits virus infectivity |
ES2141076T3 (es) | 1988-09-01 | 2000-03-16 | Bayer Ag | Proteina del receptor de rinovirus humano que inhibe la infectividad del virus. |
US6051231A (en) * | 1988-09-01 | 2000-04-18 | Bayer Corporation | Antiviral methods and prepations |
JPH02262599A (ja) * | 1989-01-03 | 1990-10-25 | Merck & Co Inc | ヒト多形核白血球からの精製C5aレセプター |
US5871733A (en) * | 1990-07-20 | 1999-02-16 | Bayer Corporation | Multimeric forms of human rhinovirus receptor protein |
DK0468257T3 (da) * | 1990-07-20 | 2000-03-27 | Bayer Ag | Multimer form af human rhinovirusreceptorprotein |
US6107461A (en) * | 1990-07-20 | 2000-08-22 | Bayer Corporation | Multimeric forms of human rhinovirus receptor and fragments thereof, and method of use |
US5674982A (en) * | 1990-07-20 | 1997-10-07 | Bayer Corporation | Multimeric form of human rhinovirus receptor protein |
AU1771192A (en) * | 1991-03-12 | 1992-10-21 | Biogen, Inc. | Monoclonal antibodies recognizing lymphocyte function associated antigen-3 |
US6764681B2 (en) | 1991-10-07 | 2004-07-20 | Biogen, Inc. | Method of prophylaxis or treatment of antigen presenting cell driven skin conditions using inhibitors of the CD2/LFA-3 interaction |
DK0786255T3 (da) * | 1991-10-07 | 2002-04-15 | Biogen Inc | Fremgangsmåde til forbedring af tolerancen for allotransplantater og xenotransplantater ved administration af et LFA-3- eller CD2-bindingsprotein |
US6162432A (en) * | 1991-10-07 | 2000-12-19 | Biogen, Inc. | Method of prophylaxis or treatment of antigen presenting cell driven skin conditions using inhibitors of the CD2/LFA-3 interaction |
EP1419236A4 (de) | 2001-07-24 | 2005-08-03 | Biogen Idec Inc | Verfahren zur behandlung von sklerotischen erkrankungen unter verwendung cd2-bindender substanzen |
CA2565259A1 (en) | 2004-05-07 | 2005-12-08 | Astellas Us Llc | Soluble lfa-3 polypeptide for treating viral disorders |
WO2016149088A1 (en) | 2015-03-13 | 2016-09-22 | Bristol-Myers Squibb Company | Use of alkaline washes during chromatography to remove impurities |
-
1988
- 1988-02-26 AT AT88301709T patent/ATE98649T1/de not_active IP Right Cessation
- 1988-02-26 DE DE88301709T patent/DE3886237T2/de not_active Expired - Fee Related
- 1988-02-26 ES ES88301709T patent/ES2061638T3/es not_active Expired - Lifetime
- 1988-02-26 EP EP88301709A patent/EP0280578B1/de not_active Expired - Lifetime
- 1988-02-26 CA CA000559923A patent/CA1326940C/en not_active Expired - Fee Related
- 1988-02-26 JP JP63044023A patent/JPS63276494A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
DE3886237D1 (de) | 1994-01-27 |
EP0280578A3 (en) | 1989-03-29 |
ES2061638T3 (es) | 1994-12-16 |
EP0280578B1 (de) | 1993-12-15 |
EP0280578A2 (de) | 1988-08-31 |
CA1326940C (en) | 1994-02-08 |
DE3886237T2 (de) | 1994-05-05 |
JPS63276494A (ja) | 1988-11-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE98649T1 (de) | Reinigung von lfa-3. | |
EP0391526A3 (de) | Reinigungsverfahren für Antikörper | |
BR9002017A (pt) | Acido 2-0-.-d-glicopiranosil-i-ascorbico cristalino,processo de sua preparacao,e seus usos | |
HUT39462A (en) | Process for the purification of proteins | |
BR8506340A (pt) | Processo de purificacao de tantalo | |
BR8701791A (pt) | Processo para separacao de monoxido de carbono tendo pureza substancialmente constante | |
DE3583043D1 (de) | Verfahren zur reinigung von podophyllotoxin. | |
KR890700609A (ko) | 정제된 혈소판으로 부터 유도한 성장 인자 및 그의 정제방법 | |
HK1013439A1 (en) | Method for the separation of lp(a) by electrophoresis and its application to the in vitro determination of atherogenic risk linked to the presence of lp(a) | |
ES2019127B3 (es) | Proceso de purificacion destilativa de tetrahidrofurano | |
EP0603671A3 (de) | Verfahren zur Reaktivierung von gereinigten Membranproteinen. | |
DK443586A (da) | Vandrensningsproces | |
ES2041690T3 (es) | Metodo para la purificacion de anticuerpos. | |
PT85956A (en) | Process for protein purification | |
FR2602772B1 (fr) | Procede de purification de l'acetate de tocopherol | |
BR8502841A (pt) | Processo de purificacao de mercaptobenzotiazola | |
ATE76300T1 (de) | Verfahren zur abtrennung und reinigung von t-pa. | |
FR2559153B1 (fr) | Procede de purification d'oxacephalosporines | |
GB8828190D0 (en) | Method for purification of tellurium & sellenium alkyls | |
EP0316964A3 (en) | Process for the purification of podophyllotoxin | |
DE68918436D1 (de) | Adsorptives Trennungsverfahren zur Reinigung von 2,6-Dimethylnaphthalin. | |
RO86214A2 (ro) | Procedeu de purificare a solutiei de 0,0-dimetil-s-(1,2-dicarbeto0ietil)-ditiofosfat tehnic | |
NO175145C (no) | Fremgangsmåte for rensing av 2,2',4,4',6,6'-hexnanitrostilben(HNS) | |
SE8603414D0 (sv) | Separeringsprocess 2 | |
RO90250A2 (ro) | Procedeu de obtinere a derivatelor proteinice purificate din micobacterii |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
UEP | Publication of translation of european patent specification | ||
REN | Ceased due to non-payment of the annual fee |